Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Top Performance

Predictions

sell
Gilead Sciences Inc

Start price
Target price
Perf. (%)
€51.42
20.10.20
€50.00
22.10.20
-1.26%
22.10.20

Known brand
Fair valuation
Leading role in innovation
Future proof or reliable business model
Traumtanz 
20.10.20 50%
buy
Regeneron Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€514.00
03.10.20
-
04.11.21
-22.67%
11.03.21

Could be worthwhile Investment >10% per year
Savour 
03.10.20 50%
buy
Regeneron Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€514.00
03.10.20
€600.00
15.10.20
-1.81%
15.10.20

Known brand
Could be worthwhile Investment >10% per year
Future proof or reliable business model
Top 10 in its market
Traumtanz 
03.10.20 50%
buy
Eli Lilly Corp.

Start price
Target price
Perf. (%)
€128.00
06.09.20
€125.00
04.11.21
-3.25%
06.11.20

Future proof or reliable business model
Higher risks for its business
Risky Investment
phonebroker 
06.09.20 50%
sell
Gilead Sciences Inc

Start price
Target price
Perf. (%)
€55.32
26.08.20
€50.00
08.10.20
-2.68%
08.10.20

Known brand
Fair valuation
Leading role in innovation
Future proof or reliable business model
Traumtanz 
26.08.20 50%
sell
Pfizer Inc.

Start price
Target price
Perf. (%)
€30.93
25.08.20
€25.62
03.09.20
-2.45%
03.09.20

Capable Management
Good culture
Innovative
Differentiated customer and product portfolio
Traumtanz 
25.08.20 50%
buy
Amgen Inc.

Start price
Target price
Perf. (%)
€207.40
25.08.20
€225.00
21.09.20
-1.23%
21.09.20

Could be worthwhile Investment >10% per year
High dividend yield expected
positive Cash Flow expected
Good rating
Traumtanz 
25.08.20 50%
sell
Gilead Sciences Inc

Start price
Target price
Perf. (%)
€55.59
19.08.20
€52.00
24.08.20
0.76%
24.08.20

Known brand
Fair valuation
Leading role in innovation
Future proof or reliable business model
Traumtanz 
19.08.20 50%
buy
Gilead Sciences Inc

Start price
Target price
Perf. (%)
€58.10
18.08.20
-
04.11.21
-12.10%
11.11.20

Could be worthwhile Investment >10% per year
Capable Management
Innovative
Market Leader or Top 3
Trip 
18.08.20 50%
buy
Abbott Laboratories

Start price
Target price
Perf. (%)
€85.17
14.08.20
€120.00
04.11.21
31.44%
05.11.21

Could be very worthwhile Investment >20% year
Revenue growth >5% per year expected
EBIT growth > 30% per year expected
Espresso 
14.08.20 50%
buy
Gilead Sciences Inc

Start price
Target price
Perf. (%)
€58.72
09.08.20
€65.00
26.08.20
-5.53%
26.08.20

geldnutzer 
09.08.20 50%
buy
Pfizer Inc.

Start price
Target price
Perf. (%)
€30.93
04.08.20
€38.00
04.11.21
0.31%
13.04.21

Could be worthwhile Investment >10% per year
Top 10 in its market
Known brand
Small cyclical dependencies
gerihouse 
04.08.20 50%
buy
Alexion Pharmaceutical Inc.

Start price
Target price
Perf. (%)
€89.92
30.07.20
€125.00
04.11.21
44.97%
21.01.21

Very capable Management
Very good company culture
Leading role in innovation
Could be very worthwhile Investment >20% year
ValueFreak 
30.07.20 50%
buy
Pfizer Inc.

Start price
Target price
Perf. (%)
€29.70
16.07.20
€33.21
25.08.20
4.15%
25.08.20

Capable Management
Good culture
Innovative
Differentiated customer and product portfolio
Traumtanz 
16.07.20 50%
buy
Pfizer Inc.

Start price
Target price
Perf. (%)
€28.65
12.07.20
-
17.10.20
9.93%
17.10.20

Could be very worthwhile Investment >20% year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
tinelchen 
12.07.20 50%
buy
Pfizer Inc.

Start price
Target price
Perf. (%)
€28.84
01.07.20
€42.69
08.07.20
-2.30%
08.07.20

Capable Management
Good culture
Innovative
Differentiated customer and product portfolio
Traumtanz 
01.07.20 50%
buy
Bristol-Myers Squibb

Start price
Target price
Perf. (%)
€49.48
19.06.20
€55.00
04.11.21
12.05%
04.04.21

Could be very worthwhile Investment >20% year
Revenue growth >5% per year expected
High dividend yield expected
Good rating
fenjal 
19.06.20 50%
buy
Gilead Sciences Inc

Start price
Target price
Perf. (%)
€70.87
08.06.20
€65.00
04.11.21
-18.67%
05.11.21

Could be worthwhile Investment >10% per year
Capable Management
Top 10 in its market
Known brand
gerihouse 
08.06.20 60%
buy
Eli Lilly Corp.

Start price
Target price
Perf. (%)
€131.66
06.06.20
€205.00
04.11.21
77.81%
05.11.21

Could be worthwhile Investment >10% per year
melinda 
06.06.20 50%
sell
Gilead Sciences Inc

Start price
Target price
Perf. (%)
€66.80
20.05.20
€60.00
25.05.20
4.09%
25.05.20

Known brand
Fair valuation
Leading role in innovation
Future proof or reliable business model
Traumtanz 
20.05.20 50%
buy
Gilead Sciences Inc

Start price
Target price
Perf. (%)
€77.59
03.05.20
€90.00
04.11.21
-25.71%
05.11.21

marge 
03.05.20 50%
sell
Gilead Sciences Inc

Start price
Target price
Perf. (%)
€76.31
30.04.20
€55.00
04.11.21
-24.47%
05.11.21

riegwe 
30.04.20 50%
buy
Gilead Sciences Inc

Start price
Target price
Perf. (%)
€77.45
30.04.20
€85.00
04.05.20
-5.28%
04.05.20

Known brand
Fair valuation
Leading role in innovation
Future proof or reliable business model
Traumtanz 
30.04.20 50%
buy
Gilead Sciences Inc

Start price
Target price
Perf. (%)
€77.15
29.04.20
€90.00
04.11.21
-25.29%
05.11.21

tamam 
29.04.20 50%
buy
Gilead Sciences Inc

Start price
Target price
Perf. (%)
€72.99
24.04.20
€85.00
04.11.21
-21.03%
05.11.21

stratec 
24.04.20 50%